
Exploring the Controversy: Does NAD+ Supplementation Induce Cancer Risk?
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
- The Peptique is LIVE! Go to https://thepeptique.com/ to get all your research peptides .As a loyal listener use the discount code POD15 to get 15% off the entire line of products.
- Have questions? Feel free to reach out to me: tarawest@westwellnessatx.com
- Want to get started the right way, but don't know where to start. Email me tarawest@westwellnessatx.com to set up a 30 minute $100 session to get your personalized protocol. A special discount on your first order will be included. These spots fill up fast so schedule today!
- Want the free peptide guide? Email me tarawest@westwellnessatx.com and comment Guide and I'll shoot it right over!
- Follow me on instagram @westwellnessatx
Takeaways:
- This podcast episode marks the 50th installment, showcasing significant growth and listener engagement.
- The primary focus of today's discussion centers on the relationship between NAD and cancer risk.
- NAD is crucial for cellular functions including energy production, DNA repair, and immune response.
- Current research presents mixed results regarding NAD's role in cancer, demanding further investigation and caution.
- NAD supplementation may not inherently cause cancer but could influence existing cancer cell behavior.
- Listeners are encouraged to conduct their own research and consider their personal health situations regarding NAD usage.
NAD+ biology, aging, immunity, DNA repair
- Covarrubias et al. “NAD+ metabolism and its roles in cellular processes during ageing” (review). https://pmc.ncbi.nlm.nih.gov/articles/PMC7963035/ PMC
- Ghanem et al. “Inhibitors of NAD+ Production in Cancer Treatment” (NAMPT/NAPRT review). https://pmc.ncbi.nlm.nih.gov/articles/PMC10889166/ PMC
- Manickam et al. “Nampt: a new therapeutic target for modulating NAD metabolism in cancer and inflammation” (2025 review). https://cdnsciencepub.com/doi/10.1139/cjpp-2024-0400 Canadian Science Publishing
Extracellular metabolism and cellular uptake (do IVs reach cells?)
- Gasparrini et al. “Enzymology of extracellular NAD metabolism” (ectoenzymes; NR/NMN/NAM import). https://pmc.ncbi.nlm.nih.gov/articles/PMC8038981/ PMC
- Yusri et al. “The role of NAD+ metabolism and its modulation” (2025 review; NR via ENTs; NMN dephosphorylation; SLC12A8 debate). https://www.nature.com/articles/s44324-025-00067-0 Nature
- Yaku et al. “NR and NMN: similarities and differences” (2025 perspective; NMN→NR conversion before uptake). https://www.science.org/doi/10.1126/sciadv.adr1538 Science
Human IV NAD+ / IV NR data
- Grant et al. “A Pilot Study… during a 6-hour intravenous infusion of NAD+” (750 mg IV NAD+, plasma/urine...
まだレビューはありません